GREENWICH LIFESCIENC

GLSI
Delayed Quote. Delayed  - 01/26 04:00:00 pm
36.54USD +1.05%

Turn to zoom
Prev.36.1600
Open36.2500
High41.7700
Low35.6805
Volume470 242
Latest news
8h ago
5d ago
01/08
01/05
Chart GREENWICH LIFESCIENCES, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance42,772,256,0
Spread/Res.-14%-49%-35%
Spread/Supp.6,1%952%952%
Support34,53,483,48
Financials
Sales 2019 - - -
Net income 2019 -3,43 M - -
Net Debt 2019 0,63 M - -
P/E ratio 2019 -
Yield 2019 -
Capitalization 464 M 464 M -
EV / Sales 2018 -
EV / Sales 2019 -
Nbr of Employees -
Free-Float 20,0%
Company
Greenwich LifeSciences, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a nine amino acid transmembrane peptide of the human epidermal growth factor receptor...

>> Read more
Sector :
Biopharmaceuticals
Calendar :
2021-02-16 Presentation

Income Statement Evolution